Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NSAID Effect on Dextrose Prolotherapy in Knee OA
NCT06911359Phase 2Recruiting
- Sponsor
- David Grant USAF Medical Center
- Start
- Mar 2025
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ibuprofen in knee osteoarthritis (OA), sponsored by David Grant USAF Medical Center. Started Mar 2025; status: recruiting.
02
Drugs
ibuprofen
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT06911359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06911359.